Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells

Authors: Esapa, Christopher T.¹; McIlhinney, R.A. Jeffrey²; Blake, Derek J.¹

Source: Human Molecular Genetics, Volume 14, Number 2, 15 January 2005 , pp. 295-305(11)

Buy & download fulltext article:

Price: $42.29 plus tax (Refund Policy)

Abstract:

Mutations in the gene encoding fukutin-related protein (FKRP) cause a spectrum of diseases including congenital muscular dystrophy type 1C (MDC1C), limb girdle muscular dystrophy 2I (LGMD2I) and congenital muscular dystrophies (CMDs) with brain malformations and mental retardation. Although these diseases are associated with abnormal dystroglycan processing, the cellular consequences of the idiosyncratic FKRP mutations have not been determined. Here we show, in cultured cells, that FKRP mutants associated with the more severe disease phenotypes (S221R, A455D, P448L) are retained in the endoplasmic reticulum (ER), whereas the wild-type protein and the mutant L276I that causes LGMD2I are found predominantly in the Golgi apparatus. The ER-retained proteins have a shorter half-life than the wild-type FKRP and are preferentially degraded by the proteasome. Furthermore, calnexin binds preferentially to the ER-retained mutants suggesting that it may participate in the quality control pathway for FKRP. These data provide the first evidence that the ER-retention of mutant FKRP may play a role in the pathogenesis of CMD and potentially explain why the allelic disorder LGMD2I is milder, because the mutated protein is able to reach the Golgi apparatus.

Keywords: communicable disease; emergency planning; healthcare associated infections; emerging infections

Document Type: Research article

DOI: http://dx.doi.org/10.1093/hmg/ddi026

Affiliations: 1: Department of Pharmacology and 2: Medical Research Council Anatomical Neuropharmacology Unit, University of Oxford, Oxford, UK

Publication date: 2005-01-15

More about this publication?